Taysha Gene Therapies Disclosed That It Has Commenced An Underwritten Public Offering Of Up To $75M Of Shares Of Its Common Stock And, In Lieu Of Common Stock To Certain Investors That So Choose, Pre-funded Warrants To Purchase Shares Of Its Common Stock
Taysha Gene Therapies Disclosed That It Has Commenced An Underwritten Public Offering Of Up To $75M Of Shares Of Its Common Stock And, In Lieu Of Common Stock To Certain Investors That So Choose, Pre-funded Warrants To Purchase Shares Of Its Common Stock
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.